MERCK & CO., INC.

Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:55 14/03/2026 am IST			5-day change	1st Jan Change
115.61 ^USD	-0.26%		-0.16%	+9.83%

12/03	Wells Fargo Adjusts Price Target on Merck & Co. to $150 From $135, Maintains Overweight Rating	MT
10/03	Merck's Winrevair Must Show Walk Distance Improvement to Build Confidence, RBC Says	MT

Chart calendar Merck & Co., Inc.

67e70a7b8662d.rBJtwYUmCGA6JsZHI3ik25EptTUzAWe4wpF6yRbk1bs.201b9-JWXxdiEZEhdjLgjaZB7FxRUAKKh8IpgnTSkOzKIw6I6kFEKBdjiw~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

16/03/2026	Ex-dividend date - 0.85 USD	09:30 am
30/04/2026	Earnings presentation	06:30 pm
29/05/2026	Earnings release - Annual 2025	Day
04/08/2026	Earnings presentation	06:30 pm
29/10/2026	Earnings presentation	06:30 pm
13/11/2026		Day

Past events on Merck & Co., Inc.

03/02/2026	Earnings presentation	07:30 pm
03/02/2026	Estimated Earnings Release Date (S&P Global Derived) - Q4 2025	~ 11:00 pm
10/11/2025	Présentation aux Actionnaires / Analystes	05:31 am
30/10/2025	Earnings presentation	06:30 pm
30/10/2025	Estimated Earnings Release Date (S&P Global Derived) - Q3 2025	~ 10:00 pm
29/07/2025	Earnings presentation	06:30 pm
29/07/2025	Estimated Earnings Release Date (S&P Global Derived) - Q2 2025	~ 10:00 pm
17/07/2025	Information meeting	06:30 pm
27/05/2025	Présentation aux Actionnaires / Analystes	06:30 pm
27/05/2025	Annual General Meeting	Day
24/04/2025	Earnings presentation	06:30 pm
24/04/2025	Estimated Earnings Release Date (S&P Global Derived) - Q1 2025	~ 10:00 pm
01/04/2025	Présentation aux Actionnaires / Analystes	05:30 pm

Past dividends on Merck & Co., Inc.

15/12/2025	Ex-dividend date - 0.85 USD	10:30 am
15/09/2025	Ex-dividend date - 0.81 USD	09:30 am
16/06/2025	Ex-dividend date - 0.81 USD	09:30 am
17/03/2025	Ex-dividend date - 0.81 USD	09:30 am

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	60 115 59 938 0.3%	64 168 63 997 0.27%	65 011 64 779 0.36%	66 707	70 434	74 998
EBITDA Million USD	Released Forecast Spread	10 083 9 362 7.71%	27 897 26 650 4.68%	32 617 29 685 9.88%	21 339	32 559	35 805
EBIT Million USD	Released Forecast Spread	6 211 6 066 2.4%	23 398 23 593 -0.83%	26 779 26 730 0.18%	18 061	29 646	32 187
Earnings before Tax (EBT) Million USD	Released Forecast Spread	1 889 2 857 -33.89%	19 936 21 364 -6.68%	21 067 22 876 -7.91%	13 960	26 343	30 118
Net income Million USD	Released Forecast Spread	365 1 682 -78.3%	17 117 17 500 -2.19%	18 254 19 815 -7.88%	10 207	21 142	23 244
EPS USD	Released Forecast Spread	0,14 0,56 -75.16%	6,74 7,01 -3.82%	7,28 7,74 -5.99%	4,28	8,67	9,65
Announcement Date		01/02/24	04/02/25	03/02/26	-

Quarterly results

Fiscal Period	December	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	16 112 15 844 1.69%	16 657 16 514 0.87%	15 624 15 507 0.76%	15 529 15 331 1.29%	15 806 15 873 -0.42%	17 276 16 978 1.76%	16 400 16 206 1.2%	15 874	16 387	17 614	16 948	17 085	17 425	18 933	18 415
EBITDA Million USD	Released Forecast Spread	7 177 7 367 -2.57%	5 466 5 999 -8.89%	6 422 7 737 -16.99%	7 722 6 882 12.2%	7 484 7 160 4.52%	8 710 8 313 4.77%	8 702 7 843 10.95%	-1 688	7 402	8 253	7 072
EBIT Million USD	Released Forecast Spread	6 659 6 519 2.14%	4 913 5 046 -2.63%	5 225 5 140 1.66%	6 623 6 533 1.38%	6 365 6 206 2.56%	7 556 7 139 5.84%	6 236 6 134 1.66%	-1 521	5 722	7 541	6 551
Earnings before Tax (EBT) Million USD	Released Forecast Spread	6 006 6 023 -0.29%	4 090 4 535 -9.82%	4 170 4 641 -10.15%	5 903 5 880 0.4%	4 999 5 672 -11.86%	6 745 6 465 4.32%	3 420 4 751 -28.02%	-3 581	5 430	6 551	5 614
Net income Million USD	Released Forecast Spread	5 455 4 942 10.38%	3 157 3 419 -7.66%	3 743 3 700 1.16%	5 079 4 983 1.93%	4 427 4 651 -4.81%	5 785 5 155 12.22%	2 963 4 341 -31.74%	-3 921	4 412	5 179	4 562
EPS USD	Released Forecast Spread	2,14 1,93 10.86%	1,24 1,43 -13.39%	1,48 1,49 -0.58%	2,01 1,93 3.97%	1,76 1,84 -4.45%	2,32 2,06 12.85%	1,19 1,68 -29.16%	-1,51	1,75	2,09	1,86
Announcement Date		30/07/24	31/10/24	04/02/25	24/04/25	29/07/25	30/10/25	03/02/26	-	-	-	-	-	-	-	-

Upcoming sector events for Merck & Co., Inc.

16/03/2026	ALK-ABELLÓ A/S	Annual General Meeting	08:30 pm
16/03/2026	ALK-ABELLÓ A/S	Présentation aux Actionnaires / Analystes	08:30 pm
16/03/2026	ALK-ABELLÓ A/S	Annual General Meeting	08:30 pm
16/03/2026	CHINA MEDICAL SYSTEM HOLDINGS LIMITED	Board of Directors Meeting	Day
16/03/2026	CHINA MEDICAL SYSTEM HOLDINGS LIMITED	Earnings release - Annual 2025	~ 10:00 am
16/03/2026	TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD	Extraordinary General Meeting	12:00 pm
16/03/2026	HYBIO PHARMACEUTICAL CO., LTD.	Extraordinary General Meeting	01:00 pm
17/03/2026	ALK-ABELLÓ A/S	Ex-dividend date - 1.6 DKK	09:30 am
17/03/2026	DERMAPHARM HOLDING SE	Earnings release - Annual 2025	10:00 pm
19/03/2026	VIATRIS INC.	Information meeting	07:30 pm

Past sector events for Merck & Co., Inc.

13/03/2026	GILEAD SCIENCES, INC.	Ex-dividend date - 0.82 USD	09:30 am
13/03/2026	AUROBINDO PHARMA	Présentation aux Actionnaires / Analystes	06:30 am
13/03/2026	GLAND PHARMA LIMITED	Présentation aux Actionnaires / Analystes	Day
13/03/2026	HISAMITSU PHARMACEUTICAL CO., INC.	Board of Directors Meeting	Day
13/03/2026	HYPERA S.A.	Earnings presentation	Day
13/03/2026	HYPERA S.A.	Earnings presentation	07:30 pm
13/03/2026	TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.	Earnings release - Annual 2025	~ 12:30 pm
13/03/2026	BORA PHARMACEUTICALS CO., LTD.	Earnings presentation	Day
13/03/2026	HAINAN HAIYAO CO., LTD.	Extraordinary General Meeting	12:30 pm
13/03/2026	BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.	Extraordinary General Meeting	11:30 am

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

Stock Market
Equities
MRK Stock
Calendar Merck & Co., Inc.

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW